Atara Biotherapeutics Inc (NASDAQ: ATRA) stock closed at $10.51 on 2/6/25 after a major increase of 12.5%. However, this advance was accompanied by below average trading volume at 71% of normal. The stock has been weak relative to the market over the last nine months but has risen 29.9% during the last week.
Current PriceTarget Research Rating
Atara Biotherapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment